- Home
- AMSC vs OCUL Comparison
AMSC vs OCUL Comparison
Compare AMSC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMSC | OCUL |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | 400 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AMSC | OCUL |
|---|---|---|
| Price | $27.70 | $9.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $52.00 | $23.56 |
| AVG Volume (30 Days) | 596.7K | ★ 2.0M |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1806.25 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $900,000.00 | ★ $1,990,000.00 |
| Revenue This Year | $34.98 | $7.93 |
| Revenue Next Year | $21.38 | $96.07 |
| P/E Ratio | $138.75 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $24.87 | $6.23 |
| 52 Week High | $70.49 | $16.44 |
Technical Indicators
Market Signals| Indicator | AMSC | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 47.26 |
| Support Level | $26.88 | $10.05 |
| Resistance Level | $33.70 | $10.78 |
| Average True Range (ATR) | 1.02 | 0.52 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 14.47 | 6.30 |
Price Performance
Historical ComparisonAbout AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.